First patient exceeding 5-year complete remission after
225
Ac-PSMA-TAT
Eur J Nucl Med Mol Imaging
.
2021 Jan;48(1):311-312.
doi: 10.1007/s00259-020-04875-y.
Epub 2020 May 28.
Authors
Hendrik Rathke
1
,
Frank Bruchertseifer
2
,
Clemens Kratochwil
3
,
Hanno Keller
4
,
Frederik L Giesel
3
5
,
Christos Apostolidis
2
,
Uwe Haberkorn
3
5
,
Alfred Morgenstern
2
Affiliations
1
Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany. hendrik.rathke@med.uni-heidelberg.de.
2
European Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.
3
Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
4
Urology Center Mannheim, Mannheim, Germany.
5
Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.
PMID:
32468252
DOI:
10.1007/s00259-020-04875-y
No abstract available
MeSH terms
Actinium*
Heterocyclic Compounds, 1-Ring*
Humans
Substances
Heterocyclic Compounds, 1-Ring
Actinium